| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/08/2005 | US6852285 Measuring variations in conformation |
| 02/08/2005 | US6851662 On-the-go sugar sensor for determining sugar content during harvesting |
| 02/08/2005 | US6851559 Analyzing and sorting of wood veneers |
| 02/08/2005 | US6851299 Measuring apparatus of component contained in test water |
| 02/08/2005 | CA2473458A1 The combination of circulating epstein-barr virus (ebv) dna in the serum or plasma of patients and a method to assess ebv subtypes for the prediction and detection of epstein-barrvirus associated cancers |
| 02/08/2005 | CA2350145C Health monitoring and diagnostic device and network-based health assessment and medical records maintenance system |
| 02/08/2005 | CA2323450C Assay of igfbp complex |
| 02/08/2005 | CA2270227C Detection of antigens via oligonucleotide antibody conjugates |
| 02/08/2005 | CA2229354C Somatic cell analyser |
| 02/08/2005 | CA2180103C Gene encoding adseverin |
| 02/08/2005 | CA2110933C Kainate-binding, human cns receptors of the eaa3 family |
| 02/05/2005 | CA2473337A1 Polymorphisms of the 5' region of the human 5-ht1a gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses |
| 02/03/2005 | WO2005011115A1 Quartz oscillator |
| 02/03/2005 | WO2005010677A2 Characterizing biological stimuli by response curves |
| 02/03/2005 | WO2005010676A2 Methods and apparatus for investigating side effects |
| 02/03/2005 | WO2005010628A1 Wood tracking by identification of surface characteristics |
| 02/03/2005 | WO2005010542A2 On-chip magnetic particle sensor with improved snr |
| 02/03/2005 | WO2005010534A1 Ep1 receptor antagonists for the treatment of benign prostatic hypertrophy and screening method |
| 02/03/2005 | WO2005010533A2 Methods and kits for the detection of prion diseases |
| 02/03/2005 | WO2005010532A1 Multiplexed binding assays for receptor arrays |
| 02/03/2005 | WO2005010531A1 Biochemical diagnostic means for screening for rheumatoid arthritis |
| 02/03/2005 | WO2005010529A1 Surface of base material being inhibited in non-specific adsorption |
| 02/03/2005 | WO2005010528A1 Method of removing nonspecific substance |
| 02/03/2005 | WO2005010527A1 Use of magnetic particles for determining binding between bioactive molecules |
| 02/03/2005 | WO2005010526A1 Method of diagnosing wood decay and decay diagnostic agent |
| 02/03/2005 | WO2005010525A1 Vacuum-packed solid support array and process for producing the same |
| 02/03/2005 | WO2005010524A1 Stem cell-based methods for identifying and characterizing agents |
| 02/03/2005 | WO2005010521A1 Photonic signal reporting of electrochemical events |
| 02/03/2005 | WO2005010519A1 Biosensor and production method therefor |
| 02/03/2005 | WO2005010518A1 Rolled electrode array and its method for manufacture |
| 02/03/2005 | WO2005010508A1 Method and system for distinguishing between materials having overlapping spectra |
| 02/03/2005 | WO2005010506A1 Method for measuring isotope concentration |
| 02/03/2005 | WO2005010505A1 Method for performing a spectroscopic measurement on particle samples and measuring device for carrying out said method |
| 02/03/2005 | WO2005010498A1 Method and apparatus for determining the amount of gas contained in a liquid |
| 02/03/2005 | WO2005010492A2 Classification of disease states using mass spectrometry data |
| 02/03/2005 | WO2005010485A2 Methods for detecting and analyzing n-glycolylneuraminic acid (neu5gc) in biological materials |
| 02/03/2005 | WO2005010484A2 Methods for identifying cell surface receptor protein modulators |
| 02/03/2005 | WO2005010483A2 Sensor arrangement |
| 02/03/2005 | WO2005010482A2 Detection of biomarkers |
| 02/03/2005 | WO2005010481A2 Preparation and use of gold glyconanoparticles |
| 02/03/2005 | WO2005010274A1 Isolation of sclereids |
| 02/03/2005 | WO2005010215A2 Methods for identifying tolerance modulatory compounds and uses therefor |
| 02/03/2005 | WO2005010211A1 Optical detection of analytes by use of semiconductor nanoparticles |
| 02/03/2005 | WO2005010208A1 Improved method of amplifying atp and use thereof |
| 02/03/2005 | WO2005010207A2 Methods and compositions for the detection of microbial contaminants |
| 02/03/2005 | WO2005010205A2 Biomarkers fo aggrecanase activity |
| 02/03/2005 | WO2005010200A2 Concurrent optimization in selection of primer and capture probe sets for nucleic acid analysis |
| 02/03/2005 | WO2005010195A1 Method of synthesizing amino-acid-selectively labeled protein |
| 02/03/2005 | WO2005010181A1 Method for detecting nucleic acid |
| 02/03/2005 | WO2005010180A1 Method of judging cancer based on the expression of homeobox gene |
| 02/03/2005 | WO2005010177A1 Non-watson crick base pair-metal complex |
| 02/03/2005 | WO2005010169A2 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 02/03/2005 | WO2005010168A2 Method and system for detecting chloramphenicol |
| 02/03/2005 | WO2005010167A2 Antibodies to the fbsa protein of streptococcus agalactiae and their use in treating or preventing infections |
| 02/03/2005 | WO2005010152A2 Human mast cell-expressed membrane protein |
| 02/03/2005 | WO2005010151A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/03/2005 | WO2005010048A2 Rg1 antibodies and uses thereof |
| 02/03/2005 | WO2005010044A2 Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| 02/03/2005 | WO2005010042A1 7a5/prognostin and use thereof for the diagnostic and therapy of tumors |
| 02/03/2005 | WO2005010035A2 Alternate reading frame polypeptides derived from hepatitis c and methods of their use |
| 02/03/2005 | WO2005010031A1 Peptides capable of binding to titanium, silver and silicone |
| 02/03/2005 | WO2005010026A2 Methods for detecting activation of t-cells by mhc binding peptides |
| 02/03/2005 | WO2005010023A2 Method for prediction of an epitope |
| 02/03/2005 | WO2005009983A1 Method for the detection of nucleophilic chemical species |
| 02/03/2005 | WO2005009952A2 Photoluminescent heterodiamondoids as biological labels |
| 02/03/2005 | WO2005009584A1 Method and apparatus for detecting chemical binding |
| 02/03/2005 | WO2005009581A2 Methods and apparatus for blood separation and analysis using membranes on an optical bio-disc |
| 02/03/2005 | WO2005009510A2 Penetration enhancer combinations for transdermal delivery |
| 02/03/2005 | WO2005009470A1 Remedy for cardiac failure comprising ask1 inhibitor as the active ingredient and method of screening the same |
| 02/03/2005 | WO2005009441A1 High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins |
| 02/03/2005 | WO2005009374A2 Ceramide dependent-stabilization of bace1 |
| 02/03/2005 | WO2005009363A2 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
| 02/03/2005 | WO2005009339A2 Inflammatory bowel diseases |
| 02/03/2005 | WO2005009225A2 Tissue adhesive sealant |
| 02/03/2005 | WO2005009224A2 Methods and compositions for evaluation and modulations of fertility |
| 02/03/2005 | WO2005009222A2 Method of determining sperm capacitation |
| 02/03/2005 | WO2005009217A2 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 02/03/2005 | WO2005009203A2 Methods and compositions for use in diagnosing and characterizing diseases involving abnormal apoptosis |
| 02/03/2005 | WO2005009202A2 Automatic identification of bioagents |
| 02/03/2005 | WO2005009119A1 Rat model of diabetic nephropathy |
| 02/03/2005 | WO2005000760A3 Non-destructive quality control method for microarray substrate coatings via labeled doping |
| 02/03/2005 | WO2004111654A3 Serum biomarkers in ischaemic heart disease |
| 02/03/2005 | WO2004106366A8 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 02/03/2005 | WO2004105153A3 Micro/nano fluidic 3-dimensional electrode system |
| 02/03/2005 | WO2004104574A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor type 7 (ccr7) |
| 02/03/2005 | WO2004102195A8 Method for identifying tff2 regulating agents and agents identified using said method |
| 02/03/2005 | WO2004100773A3 Diagnostic and therapeutic treatments related to mitochondrial disorders |
| 02/03/2005 | WO2004100760A8 Predicting cancer progression |
| 02/03/2005 | WO2004097041A3 Screening method for binding molecules |
| 02/03/2005 | WO2004094987A3 Kit for detecting endotoxin in aqueous solutions |
| 02/03/2005 | WO2004094594A3 Non-human animal model for graft-versus-host disease |
| 02/03/2005 | WO2004085995A3 Analyte concentration detection devices and methods |
| 02/03/2005 | WO2004085994A3 Erythrocyte sedimentation rate (esr) test measurement instrument of unitary design and method of using the same |
| 02/03/2005 | WO2004083175A3 Methods for identifying enzyme inhibitors and protein kinases |
| 02/03/2005 | WO2004081175A3 Methods and compositions for purification of nucleic acid from a host cell |
| 02/03/2005 | WO2004071273A3 Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus |
| 02/03/2005 | WO2004069983A9 Microreactor architecture and methods |
| 02/03/2005 | WO2004061087A3 Methods and compositions of ecdysozoan molt inhibition |
| 02/03/2005 | WO2004046689B1 System and method for multiplexed biomolecular analysis |
| 02/03/2005 | WO2004038005A3 Methods of identifying reduced internalization transmembrane receptor agonists |